Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.5%

1 terminated/withdrawn out of 196 trials

Success Rate

96.9%

+10.3% vs industry average

Late-Stage Pipeline

13%

25 trials in Phase 3/4

Results Transparency

0 of 31 completed trials have results

Key Signals

77 recruiting

Enrollment Performance

Analytics

Phase 2

49(34.5%)

N/A

48(33.8%)

Phase 1

17(12.0%)

Phase 3

14(9.9%)

Phase 4

11(7.7%)

Early Phase 1

3(2.1%)

142Total

Phase 2(49)

N/A(48)

Phase 1(17)

Phase 3(14)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (196)

Showing 20 of 196 trials

NCT07692555Not Yet Recruiting

Development and Validation of a Colorectal Cancer Diagnostic Model

Role: collaborator

NCT07686796Phase 3Not Yet Recruiting

Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial

Role: collaborator

NCT07159035Not ApplicableCompleted

Flexible Ureteroscopy With a Flexible and Navigable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy for 1-2 cm Lower Pole Kidney Stones

Role: collaborator

NCT07677787Not ApplicableRecruiting

DLL3-Targeted PET/CT in Small Cell Lung Cancer

Role: lead

NCT07677774Not ApplicableRecruiting

GPC3-Targeted PET/CT in Hepatocellular Carcinoma

Role: lead

NCT07133620Not ApplicableRecruiting

the Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Gastrointestinal Dysfunction After Urological Laparoscopic Surgery

Role: lead

NCT07452406Not ApplicableNot Yet Recruiting

Protocolized Weaning of High-Flow Nasal Cannula in Adult Patients

Role: collaborator

NCT07623382Early Phase 1Recruiting

Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles for the Treatment of Dry Eye Disease

Role: lead

NCT07622693Active Not Recruiting

Beta-Blockers on Neoadjuvant Immunochemotherapy for Hypertensive Patients With Gastric Cancer

Role: collaborator

NCT07617675Phase 4Not Yet Recruiting

rhBNP for Prevention of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)

Role: collaborator

NCT06465017Not ApplicableTerminated

ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer

Role: lead

NCT07588867Not ApplicableCompleted

The Combined Multicomponent Intervention Specifically in Rural Community Older Adults at High Risk for Mild Cognition Impairment

Role: collaborator

NCT06754345Recruiting

68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers

Role: lead

NCT05780372Phase 3Active Not Recruiting

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

Role: collaborator

NCT07577050Phase 2Not Yet Recruiting

A Phase II Study of NB001 for Acute Migraine Treatment

Role: collaborator

NCT04436965Phase 3Recruiting

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

Role: collaborator

NCT05524168Phase 2Active Not Recruiting

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

Role: collaborator

NCT07568639Not ApplicableNot Yet Recruiting

Multi-Site Cortical Puncture for DOR

Role: collaborator

NCT04518475Phase 4Recruiting

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Role: collaborator

NCT07547930Phase 2Recruiting

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

Role: lead